Tom Gibbs

30 years’ international experience with responsibility for operations, marketing, business development and investment in both start-ups and established life science companies, including Molecular Devices Corp, Covalys, Med Discovery, Debiopharm. Presently Director at Debiopharm Innovation Fund, Switzerland. Current and recent board experience includes BC Platforms, Kaiku Health, Biocartis, GenePOC.